An observational study in To Report the Rare Occurrence of Meckel's Diverticulum, sponsored by Haramaya Unversity. Completed at 1 site in Ethiopia. Open to participants aged 4 Years to 33 Years. Per ClinicalTrials.gov, last updated 2023-03-31.
Sponsored by Haramaya Unversity · Observational
Acas series study was conducted on emergency acute abdomen patients who finally confirmed intraoperatively as Meckel's diverticulum with different complications. Simple perforation to isolated axial torsioned gangrene was observed. The patients signed consent for their cases to be published.
The study was aimed at reporting the rare complications of Meckel's diverticulum, which were diagnosed intraoperatively among acute abdomen patients presented to HFCSH. The patients had different complications ranging from simple isolated perforation to gangrenous Meckel's diverticulum. All of the patients gave their informed written and signed consent for publication.
31 studies on the registry are indexed under Intussusception; 6 are open to participants now.
This study's enrollment of 4 is below the median of 250 across 15 observational studies indexed under Intussusception.
Browse Intussusception studies →Haramaya Unversity is the lead sponsor of 9 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
patients who presented with the diagnosis of acute abdomen
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
all patients were operated after being admitted to surgical ward for acute abdomen
Outcome upon discharge
outcome of patients with different complications were reported even though there was no death.
Time frame: 10 months
Plan to share: No — Its against our institutions rule and regulations to share patient data to the third party
No publications or documents are linked to this record.
Ran from Jan 2022 to primary completion in Oct 2022, 9 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Haramaya Unversity